Related references
Note: Only part of the references are listed.Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Adrian Murray Brunt et al.
LANCET (2020)
Metabolic Reprogramming in Triple-Negative Breast Cancer
Sun Xiangyu et al.
FRONTIERS IN ONCOLOGY (2020)
Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications
Tiziana Tataranni et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Dichloroacetate is an antimetabolite that antagonizes acetate and deprives cancer cells from its benefits: A novel evidence-based medical hypothesis
Salah Mohamed El Sayed et al.
MEDICAL HYPOTHESES (2019)
Dichloroacetate Ameliorates Cardiac Dysfunction Caused by Ischemic Insults Through AMPK Signal PathwayNot Only Shifts Metabolism
Xuan Li et al.
TOXICOLOGICAL SCIENCES (2019)
Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?
Hui Wang et al.
CANCERS (2019)
Role of metabolism in cancer cell radioresistance and radiosensitization methods
Le Tang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors
Wen Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2018)
The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance
Benjamin L. Woolbright et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Molecular Subtypes and Local-Regional Control of Breast Cancer
Simona Maria Fragomeni et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption
Sven de Mey et al.
FRONTIERS IN PHARMACOLOGY (2018)
A framework for large-scale metabolome drug profiling links coenzyme A metabolism to the toxicity of anti-cancer drug dichloroacetate
Sebastien Dubuis et al.
COMMUNICATIONS BIOLOGY (2018)
Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib
Amir Noeparast et al.
ONCOTARGET (2017)
Preoperative breast radiation therapy: Indications and perspectives
S. V. Lightowlers et al.
EUROPEAN JOURNAL OF CANCER (2017)
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
Peter W. Stacpoole
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells
Giulia Cesi et al.
MOLECULAR CANCER (2017)
Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1
Margaret O. James et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Suppression of pyruvate dehydrogenase kinase-2 re-sensitizes paclitaxel-resistant human lung cancer cells to paclitaxel
Hong Sun et al.
ONCOTARGET (2017)
Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species
Hui Wang et al.
ONCOTARGET (2017)
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
Peter W. Stacpoole
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Metabolic analysis of radioresistant medulloblastoma stem-like clones and potential therapeutic targets
Lue Sun et al.
PLOS ONE (2017)
Hypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells
Iman Azimi et al.
SCIENTIFIC REPORTS (2017)
Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
Jan Poleszczuk et al.
BREAST CANCER RESEARCH (2017)
The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents
Elise Saunier et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth
Florence Polet et al.
ONCOTARGET (2016)
Mechanism of antineoplastic activity of lonidamine
Kavindra Nath et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer
Jong-Lyel Roh et al.
CANCER LETTERS (2016)
PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis
Debangshu Samanta et al.
CANCER RESEARCH (2016)
Acidosis Drives the Reprogramming of Fatty Acid Metabolism in Cancer Cells through Changes in Mitochondrial and Histone Acetylation
Cyril Corbet et al.
CELL METABOLISM (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia
Kui Song et al.
ONCOLOGY LETTERS (2016)
Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels
Gaochao Dong et al.
ONCOTARGET (2016)
Hypoxia-induced autophagy as an additional mechanism in human osteosarcoma radioresistance
Helin Feng et al.
JOURNAL OF BONE ONCOLOGY (2016)
Clinical implications of the intrinsic molecular subtypes of breast cancer
Aleix Prat et al.
BREAST (2015)
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
Fanny Dupuy et al.
CELL METABOLISM (2015)
Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cells
Kah Tan Allen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
Wen Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response Biomarkers
Janet K. Horton et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism
Han Shen et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Mitochondrial induction as a potential radio-sensitizer in lung cancer cells - a short report
Ronen Shavit et al.
CELLULAR ONCOLOGY (2015)
Targeting AMPK for cancer prevention and treatment
Weidong Li et al.
ONCOTARGET (2015)
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
H. B. Ragnum et al.
BRITISH JOURNAL OF CANCER (2015)
Mito-DCA: A Mitochondria Targeted Molecular Scaffold for Efficacious Delivery of Metabolic Modulator Dichloroacetate
Rakesh K. Pathak et al.
ACS CHEMICAL BIOLOGY (2014)
Dichloroacetate and cancer: New home for an orphan drug?
Shyam Kankotia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Targeting of two aspects of metabolism in breast cancer treatment
Bevan P. Gang et al.
CANCER BIOLOGY & THERAPY (2014)
Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism
Yi Xuan et al.
EXPERIMENTAL CELL RESEARCH (2014)
Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors
E. M. Dunbar et al.
INVESTIGATIONAL NEW DRUGS (2014)
AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells
Tsutomu Shimura et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S. Sabharwal et al.
NATURE REVIEWS CANCER (2014)
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
Y-C Shen et al.
BRITISH JOURNAL OF CANCER (2013)
PDK1 inhibition is a novel therapeutic target in multiple myeloma
S. Fujiwara et al.
BRITISH JOURNAL OF CANCER (2013)
Combined Targeting of PDK1 and EGFR Triggers Regression of Glioblastoma by Reversing the Warburg Effect
Kiran Kumar Velpula et al.
CANCER RESEARCH (2013)
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target
Hoon Hur et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Mitochondrial activation by inhibition of PDKII suppresses HIF1α signaling and angiogenesis in cancer
G. Sutendra et al.
ONCOGENE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Dichloroacetate induces tumor-specific radiosensitivity in vitro but attenuates radiation-induced tumor growth delay in vivo
F. Zwicker et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2013)
Arsenic Trioxide Treatment Decreases the Oxygen Consumption Rate of Tumor Cells and Radiosensitizes Solid Tumors
Caroline Diepart et al.
CANCER RESEARCH (2012)
Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
Yunfei Zhou et al.
CANCER RESEARCH (2012)
Inactivation of the HIF-1α/PDK3 Signaling Axis Drives Melanoma toward Mitochondrial Oxidative Metabolism and Potentiates the Therapeutic Activity of Pro-Oxidants
Jerome Kluza et al.
CANCER RESEARCH (2012)
PREOPERATIVE SINGLE FRACTION PARTIAL BREAST RADIOTHERAPY FOR EARLY-STAGE BREAST CANCER
Manisha Palta et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Overexpression of Pyruvate Dehydrogenase Kinase 3 Increases Drug Resistance and Early Recurrence in Colon Cancer
Chun-Wun Lu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex
Jean-Marc Blouin et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
F. M. Buffa et al.
BRITISH JOURNAL OF CANCER (2010)
Glycolytic metabolism and tumour response to fractionated irradiation
Ulrike G. A. Sattler et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Metabolic Modulation of Glioblastoma with Dichloroacetate
E. D. Michelakis et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Retrospective Study of Neoadjuvant Versus Adjuvant Radiochemotherapy in Locally Advanced Noninflammatory Breast Cancer Survival Advantage in cT2 Category by Neoadjuvant Radiochemotherapy
Stephan Ludwig Roth et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2010)
Phenylalanine-induced leucopenia in genetic and dichloroacetic acid generated deficiency of glutathione transferase Zeta
Angelo Theodorators et al.
BIOCHEMICAL PHARMACOLOGY (2009)
STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect
Sean P. Pitroda et al.
BMC MEDICINE (2009)
Mitochondrial Mutations Contribute to HIF1α Accumulation via Increased Reactive Oxygen Species and Up-regulated Pyruvate Dehydrogenease Kinase 2 in Head and Neck Squamous Cell Carcinoma
Wenyue Sun et al.
CLINICAL CANCER RESEARCH (2009)
Cytotoxicity,radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose In vitro
B. S. Dwarakanath
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
E. D. Michelakis et al.
BRITISH JOURNAL OF CANCER (2008)
PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer
S. M. Wigfield et al.
BRITISH JOURNAL OF CANCER (2008)
Phase II study of preoperative helical tomotherapy for rectal cancer
Mark De Ridder et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells
Thomas McFate et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation
Wengang Cao et al.
PROSTATE (2008)
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Sebastien Bonnet et al.
CANCER CELL (2007)
The radiosensitizing effect of immunoadjuvant OM-174 requires cooperation between immune and tumor cells through interferon-gamma and inducible nitric oxide synthase
Mark De Ridder et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia
Robert D. Guzy et al.
EXPERIMENTAL PHYSIOLOGY (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Deficiency of glutathione transferase zeta causes oxidative stress and activation of antioxidant response pathways
AC Blackburn et al.
MOLECULAR PHARMACOLOGY (2006)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1α during hypoxia -: A mechanism of O2 sensing
NS Chandel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
